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Introduction
Neurological cancer and other neurodegenerative diseases are amongst the
most crippling illnesses with the greater portion of infected individuals not
projected to survive past five years of initial diagnosis depending on the
severity, stage, and form of the disease; the research in this project will
identify the neurological molecular mechanisms of specific biological
markers increasingly found to be identified in instances of these diseases,
specifically c Jun kinase, which upon identification will be inhibited by
utilizing SAB antibodies. Consequently, further damage such as mutation in
the mitochondrial DNA and stress including cascades of apoptotic signaling
pathways will be entirely halted, providing a highly effective treatment to
the aforementioned neurodegenerative diseases.
Hypothesis
I propose that upon further research with the interaction of SAB and c Jun
kinase, that there will be a highly interdependent molecular reaction revealed
that links the inhibition of JNK kinase to the presence of the SAB, or
SH3BP5, gene.
Methods
The major methods that I will use throughout the course of this research
includes the use of the Western Blot Protocol in conjunction with the
extensive cell culture of brain cancer cell lines including JNK and wild-type.
This protocol will utilize specific proteins from these cell lines and blot them
with antibodies of common mitochondrial outer membrane mediators. The
proteins will first be ran through a selective membrane via gel
electrophoresis that allows for progressive movement based on molecular
weight; increased weight produces greater facility in movement on the
membrane. Under specific radiation, these will fluoresce in order to provide
a correlation or lack thereof between the protein and antibody.

Significance
My project is innovative in that it will provide further insight into the very
nature of the interaction of JNK and SAB, seeking to develop a SAB isotope
that will effectively inhibit JNK kinase. This may provide an effective
treatment to terminate neurodegenerative disease by inhibiting a major
stressor in order to prevent further mutation or dysfunction in molecular
mechanisms associated with numerous neurodegenerative diseases.

